Bristol Myers Squibb announced results from the Phase 3 VALOR-HCM study, which showed the addition of mavacamten, an investigational, first-in-class cardiac myosin inhibitor, significantly...
Angelini Pharma, international pharmaceutical company part of the privately held Italian Angelini Group announced that ONTOZRY® (cenobamate) is now available in the Netherlands for...
Global technology firm Digital Intelligence Systems, LLC (DISYS) announced a partnership with ComplianceQuest, the leading provider of 100% cloud-native, AI-powered, Enterprise Clinical, Quality Health,...
Reata Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company, announced the completion of the rolling submission of a New Drug Application (“NDA”) to the U.S. Food...
Epiphany Dermatology, a leading dermatology company committed to improving access to exceptional dermatologic care, announced it has expanded its presence in the Rocky Mountain...
